Format
Sort by
Items per page

Send to

Choose Destination

Best matches for atrial fibrillation AND hypertrophic cardiomyopathy AND mortality vital statistics:

Search results

Items: 1 to 20 of 175

1.

Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.

Collis R, Watkinson O, O'Mahony C, Guttmann OP, Pantazis A, Tome-Esteban M, Tsang V, Chandrasekaran V, McGregor CGA, Elliott PM.

Eur J Heart Fail. 2017 Nov 16. doi: 10.1002/ejhf.1038. [Epub ahead of print]

PMID:
29148156
2.

Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy.

Rowin EJ, Maron MS, Chan RH, Hausvater A, Wang W, Rastegar H, Maron BJ.

Am J Cardiol. 2017 Sep 20. pii: S0002-9149(17)31471-6. doi: 10.1016/j.amjcard.2017.08.048. [Epub ahead of print]

PMID:
29111210
3.

Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC).

Goland S, van Hagen IM, Elbaz-Greener G, Elkayam U, Shotan A, Merz WM, Enar SC, Gaisin IR, Pieper PG, Johnson MR, Hall R, Blatt A, Roos-Hesselink JW.

Eur Heart J. 2017 Sep 14;38(35):2683-2690. doi: 10.1093/eurheartj/ehx189.

PMID:
28934836
4.

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W, Rastegar H, Estes NAM 3rd, Maron MS, Maron BJ.

Circulation. 2017 Sep 15. pii: CIRCULATIONAHA.117.029267. doi: 10.1161/CIRCULATIONAHA.117.029267. [Epub ahead of print]

PMID:
28916640
5.

Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Dominguez F, Climent V, Zorio E, Ripoll-Vera T, Salazar-Mendiguchía J, García-Pinilla JM, Urbano-Moral JA, Fernández-Fernández X, Lopez-Cuenca D, Ajo-Ferrer R, Sanz-Sanchez J, Gomez-Perez Y, López-Garrido MA, Barriales-Villa R, Gimeno JR, Garcia-Pavia P.

Int J Cardiol. 2017 Dec 1;248:232-238. doi: 10.1016/j.ijcard.2017.08.010. Epub 2017 Aug 7.

PMID:
28811092
6.

Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Vaidya K, Semsarian C, Chan KH.

Heart Lung Circ. 2017 Sep;26(9):975-982. doi: 10.1016/j.hlc.2017.05.116. Epub 2017 May 23. Review.

PMID:
28602671
7.

Plasma level of big endothelin-1 predicts the prognosis in patients with hypertrophic cardiomyopathy.

Wang Y, Tang Y, Zou Y, Wang D, Zhu L, Tian T, Wang J, Bao J, Hui R, Kang L, Song L, Wang J.

Int J Cardiol. 2017 Sep 15;243:283-289. doi: 10.1016/j.ijcard.2017.03.162. Epub 2017 Apr 20.

PMID:
28587741
8.

Association of elevated pulmonary artery systolic pressure with stroke and systemic embolic events in patients with hypertrophic cardiomyopathy.

Kanbayashi K, Minami Y, Haruki S, Maeda R, Itani R, Ashihara K, Hagiwara N.

Int J Cardiol. 2017 Aug 1;240:320-323. doi: 10.1016/j.ijcard.2017.05.019. Epub 2017 May 5.

PMID:
28499672
9.

Usefulness of Preoperative Transforming Growth Factor-Beta to Predict New Onset Atrial Fibrillation After Surgical Ventricular Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.

Guo Y, Wu X, Zheng X, Lu J, Wang S, Huang X.

Am J Cardiol. 2017 Jul 1;120(1):118-123. doi: 10.1016/j.amjcard.2017.03.252. Epub 2017 Apr 12.

PMID:
28483207
10.

Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.

Lee SE, Park JK, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B.

Heart. 2017 Oct;103(19):1496-1501. doi: 10.1136/heartjnl-2016-310720. Epub 2017 Apr 20.

PMID:
28428444
11.

Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy†.

Lapenna E, Pozzoli A, De Bonis M, La Canna G, Nisi T, Nascimbene S, Vicentini L, Di Sanzo S, Del Forno B, Schiavi D, Alfieri O.

Eur J Cardiothorac Surg. 2017 Jun 1;51(6):1112-1118. doi: 10.1093/ejcts/ezx017.

PMID:
28329110
12.

Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy.

van Velzen HG, Theuns DA, Yap SC, Michels M, Schinkel AF.

Am J Cardiol. 2017 Jan 1;119(1):100-105. doi: 10.1016/j.amjcard.2016.08.092. Epub 2016 Sep 29.

PMID:
28247846
13.

Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.

Zegkos T, Efthimiadis GK, Parcharidou DG, Gossios TD, Giannakoulas G, Ntelios D, Ziakas A, Paraskevaidis S, Karvounis HI.

Hellenic J Cardiol. 2017 Feb 20. pii: S1109-9666(16)30241-X. doi: 10.1016/j.hjc.2017.01.027. [Epub ahead of print]

14.

Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis.

Masri A, Kanj M, Thamilarasan M, Wazni O, Smedira NG, Lever HM, Desai MY.

Cardiovasc Diagn Ther. 2017 Feb;7(1):36-44. doi: 10.21037/cdt.2016.11.23.

15.

Predictors of atrial fibrillation in hypertrophic cardiomyopathy.

Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators.

Heart. 2017 May;103(9):672-678. doi: 10.1136/heartjnl-2016-309672. Epub 2016 Oct 28.

PMID:
27794017
16.

Update on hypertrophic cardiomyopathy and a guide to the guidelines.

Sen-Chowdhry S, Jacoby D, Moon JC, McKenna WJ.

Nat Rev Cardiol. 2016 Nov;13(11):651-675. doi: 10.1038/nrcardio.2016.140. Epub 2016 Sep 29. Review.

PMID:
27681577
17.

[Long-term outcome and related predictors of alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy].

Liu R, Qiao SB, Hu FH, Yang WX, Yuan JS, Cui JG.

Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Sep 24;44(9):771-776. doi: 10.3760/cma.j.issn.0253-3758.2016.09.008. Chinese.

PMID:
27667275
18.

Prognostic Implications of Left Ventricular Scar Determined by Late Gadolinium Enhanced Cardiac Magnetic Resonance in Patients With Atrial Fibrillation.

Suksaranjit P, McGann CJ, Akoum N, Biskupiak J, Stoddard GJ, Kholmovski EG, Navaravong L, Rassa A, Bieging E, Chang L, Haider I, Marrouche NF, Wilson BD.

Am J Cardiol. 2016 Oct 1;118(7):991-7. doi: 10.1016/j.amjcard.2016.06.054. Epub 2016 Jul 18.

PMID:
27553101
19.

Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.

Dhillon A, Khanna A, Randhawa MS, Cywinski J, Saager L, Thamilarasan M, Lever HM, Desai MY.

Heart. 2016 Oct 15;102(20):1627-32. doi: 10.1136/heartjnl-2016-309442. Epub 2016 Jun 10.

PMID:
27288277
20.

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?

Park KM, Im SI, Kim EK, Lee SC, Park SJ, Kim JS, On YK.

PLoS One. 2016 Jun 3;11(6):e0156410. doi: 10.1371/journal.pone.0156410. eCollection 2016.

Supplemental Content

Loading ...
Support Center